Crosslinking treatment of progressive keratoconus: New hope

Current Opinion in Ophthalmology

Volumn 17, Issue 4, 2006, Pages 356-360

  Wollensak, Gregor ^a,b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b NONE   (Germany)

Author keywords

Biomechanics; Cornea; Crosslinking; Keratoconus; Riboflavin; UVA

Indexed keywords

PHOTOSENSITIZING AGENT; RIBOFLAVIN;

BOWMAN MEMBRANE; CLINICAL TRIAL; CORNEA; CORNEA CELL; CORNEA ENDOTHELIUM; CORNEA STROMA; CORNEA TRANSPLANTATION; CROSS LINKING; CYTOTOXICITY; HUMAN; KERATOCONUS; LABORATORY TEST; NONHUMAN; PARAMETERS OF MEASUREMENT AND ANALYSIS; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SUNBURN; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; VISUAL ACUITY;

ANIMALS; COLLAGEN; CORNEA; CROSS-LINKING REAGENTS; DISEASE PROGRESSION; HUMANS; KERATOCONUS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; TREATMENT OUTCOME; ULTRAVIOLET RAYS;

EID: 33747042204     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.icu.0000233954.86723.25     Document Type: Review

References (28)

1. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003; 135:620-627.
2. Wollensak G, Sporl E, Seiler T. Treatment of keratoconus by collagen crosslinking [in German]. Ophthalmologe 2003; 100:44-49.
3. Kaufman HE. Strengthening the cornea. Cornea 2004; 23:432.
4. Labetoulle M. An alternative to corneal transplantation in keratoconus treatment? [in French]. J Fr Ophtalmol 2003; 26:1097-1098.
5. Seiler T, Huhle S, Spoerl E, Kunath H. Manifest diabetes and keratoconus: a retrospective case-control study. Graefe's Arch Clin Exp Ophthalmol 2000; 238:822-825.
6. Sady C, Khosrof S, Nagaraj R. Advanced Maillard reaction and crosslinking of corneal collagen in diabetes. Biochem Biophys Res Comm 1995; 214:793-797.
7. Sung H-W, Chang W-H, Ma C-Y, Lee M-H. Crosslinking of biological tissues using genipin and/or carbodiimide. J Biomed Mater Res 2003; 64A:427-438.
8. Krishna CM, Uppuluri S, Riesz P, et al. A study of the photodynamic efficiencies of some eye lens constituents. Photochem Photobiol 1991; 54:51-58.
9. Sandner D, Spörl E, Kohlhaas M, et al. Collagen crosslinking by combined riboflavin/ultraviolet-A (UVA) treatment can stop the progression of keratoconus [abstract]. Invest Ophthalmol Vis Sci 2004; 45:E-abstract 2887.
10. Braun E, Kanellopoulos J, Pe L, Jankov M. Riboflavin/ultraviolet A-induced collagen cross-linking in the management of keratoconus [abstract]. Invest Ophthalmol Vis Sci 2005; 46:4964.
11. Dupps WJ, Netto MV, Krueger RR, Herekar S. Surface wave elastometry of the cornea: effects of epithelial debridement and central keratotomy [abstract]. Invest Ophthalmol Vis Sci 2005; 46:E-abstract 2758.
12. Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cat Refr Surg 2003; 29:1780-1785.
13. Spoerl E, Wollensak G, Dittert DD, Seiler T. Thermomechanical behavior of collagen-cross-linked porcine cornea. Ophthalmologica 2004; 218:136-140.
14. Wollensak G, Wilsch M, Spoerl E, Seiler T. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA. Cornea 2004; 23:503-507.
15. Faulborn J, Dunker S, Bowald S. Diabetic vitreopathy: findings using the celloidin embedding technique. Ophthalmologica 1998; 212:369-376.
16. Wollensak G, Spoerl E, Wilsch M, Seiler T. Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment. Cornea 2004; 23:43-49.
17. Wollensak G, Spoerl E, Reber F, Seiler T. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro. Eye 2004; 18:718-722.
18. Schilde T, Spoerl E, Kohlhaas M, Pillunat LE. Depth dependence of stiffening on riboflavin/UVA treated corneas. Invest Ophthalmol Vis Sci 2005; 46:E-abstract 4958.
19. Kohlhaas M, Spoerl E, Schilde T, et al. Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin, ultraviolet A light. J Cat Refr Surg 2006; 32:279-283.
20. Wollensak G, Vogten H. Microfistola corneale in caso di cheratocono acuto. Boll Ocul 2004; 83:235-238.
21. Müller LJ, Pels E, Vrensen GFJM. The specific architecture of the anterior stroma accounts for maintenance of corneal curvature. Br J Ophthalmol 2002; 85:437-443.
22. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res 2004; 29:35-40.
23. Podskochy A. Protective role of corneal epithelium against ultraviolet radiation damage. Acta Ophthalmol Scand 2004; 82:714-717.
24. Pitts DG, Cullen AP, Hacker PD. Ocular effects of ultraviolet radiation from 295-365 nm. Invest Ophthalmol Vis Sci 1977; 16:932-939.
25. Wollensak G, Spoerl E, Wilsch M, Seiler T. Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit. J Cataract Refract Surg 2003; 29:1786-1790.
26. Wollensak G, Sporl E, Reber F, et al. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophthalmic Res 2003; 35:324-328.
27. Zuclich JA. Ultraviolet-induced photochemical damage in ocular tissues. Health Physics 1989; 56:671-682.
28. Avitabile T, Marano F, Uva MG, Reibaldi A. Evaluation of central and peripheral corneal thickness with ultrasound biomicroscopy in normal and keratoconic eyes. Cornea 1997; 16:639-644.